Ignite Creation Date:
2025-12-24 @ 4:25 PM
Ignite Modification Date:
2026-02-06 @ 8:42 PM
Study NCT ID:
NCT05085366
Status:
TERMINATED
Last Update Posted:
2025-12-15
First Post:
2021-10-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
Sponsor:
ModernaTX, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cytomegalovirus Infection | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | mRNA-1647 | View |
| None | Moderna | View |
| None | Cytomegalovirus | View |
| None | CMV | View |
| None | Cytomegalovirus Vaccine | View |
| None | Cytomegalovirus Infections | View |
| None | Cytomegalovirus Congenital | View |
| None | Virus Diseases | View |
| None | Infection Viral | View |
| None | DNA Virus Infections | View |
| None | Messenger RNA | View |